Trending

antifungal

Exclusive Interview with Martin Everett, CSO, Antabio, speaking at Superbugs & Superdrugs

Exclusive Interview with Martin Everett, CSO, Antabio, speaking at Superbugs & Superdrugs

Exclusive Interview with Martin Everett

X

Exclusive Interview with Martin Everett, CSO, Antabio, speaking at Superbugs & Superdrugs

https://pharmaphorum.com/partner-content/exclusive-interview-with-martin-everett-cso-antabio-speaking-at-superbugs-superdrugs/

Vical slashes staff after culling phase II antifungal

Vical slashes staff after culling phase II antifungal

US biotech Vical is planning another round of job cuts after deciding to abandon its antifungal drug VL-2397,

X

Vical slashes staff after culling phase II antifungal

https://pharmaphorum.com/news/vical-staff-culling-phase-ii-antifungal/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com